Literature DB >> 16938381

Expression of single-chain antibody-barstar fusion in plants.

Ekaterina G Semenyuk1, Oleg A Stremovskiy, Evelina F Edelweiss, Olga V Shirshikova, Taras G Balandin, Yaroslav I Buryanov, Sergey M Deyev.   

Abstract

We successfully cloned and expressed a single-chain antibody (425scFv), that is directed to human epidermal growth factor receptor HER1 (EGFR) in transgenic tobacco plants as a fusion with bacterial barstar gene (425scFv-barstar). Plant-produced recombinant 425scFv-barstar was recovered using barstar-barnase system. Based on barstar-barnase affinity, during purification of the plant-produced 425scFv-barstar, we generated bispecific scFv-antibody heterodimers from individual single-chain fragments initially produced in different host systems with binding activity to both HER1 and HER2/neu tumor antigens. We demonstrated by flow cytometry and indirect immunofluorescent microscopy that both the components of heterodimer retain its specific cell-binding activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16938381     DOI: 10.1016/j.biochi.2006.07.012

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  11 in total

1.  Fluorescent nanodiamond bioconjugates on the base of barnase:barstar module.

Authors:  E A Ivukina; V K A Sreenivasan; O A Stremovskiy; B V Veryugin; S V Lukash; A V Zvyagin; S M Deyev; R V Petrov
Journal:  Dokl Biochem Biophys       Date:  2011-11-19       Impact factor: 0.788

2.  Protein-assisted self-assembly of multifunctional nanoparticles.

Authors:  Maxim P Nikitin; Tatiana A Zdobnova; Sergey V Lukash; Oleg A Stremovskiy; Sergey M Deyev
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

3.  Expression of recombinant antibody (single chain antibody fragment) in transgenic plant Nicotiana tabacum cv. Xanthi.

Authors:  S Dobhal; V K Chaudhary; A Singh; D Pandey; A Kumar; S Agrawal
Journal:  Mol Biol Rep       Date:  2013-11-12       Impact factor: 2.316

4.  Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts.

Authors:  Taras G Balandin; Evelina Edelweiss; Natalia V Andronova; Elena M Treshalina; Alexander M Sapozhnikov; Sergey M Deyev
Journal:  Invest New Drugs       Date:  2009-09-30       Impact factor: 3.850

5.  Production of recombinant single chain antibodies (scFv) in vegetatively reproductive Kalanchoe pinnata by in planta transformation.

Authors:  Yuchul Jung; Yong Rhee; Chung-Kyoon Auh; Hyekyung Shim; Jung-Jin Choi; Suk-Tae Kwon; Joo-Sung Yang; Donggiun Kim; Myung-Hee Kwon; Yong-Sung Kim; Sukchan Lee
Journal:  Plant Cell Rep       Date:  2009-08-18       Impact factor: 4.570

6.  Heterodimeric barnase-barstar vaccine molecules: influence of one versus two targeting units specific for antigen presenting cells.

Authors:  Heidi Cecilie Larsen Spång; Ranveig Braathen; Bjarne Bogen
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Plant-made trastuzumab (herceptin) inhibits HER2/Neu+ cell proliferation and retards tumor growth.

Authors:  Tatiana V Komarova; Vyacheslav S Kosorukov; Olga Y Frolova; Igor V Petrunia; Ksenia A Skrypnik; Yuri Y Gleba; Yuri L Dorokhov
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

8.  Modern Technologies for Creating Synthetic Antibodies for Clinical application.

Authors:  S M Deyev; E N Lebedenko
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

Review 9.  The making of bispecific antibodies.

Authors:  Ulrich Brinkmann; Roland E Kontermann
Journal:  MAbs       Date:  2017 Feb/Mar       Impact factor: 5.857

10.  Self-assembling complexes of quantum dots and scFv antibodies for cancer cell targeting and imaging.

Authors:  Tatiana A Zdobnova; Oleg A Stremovskiy; Ekaterina N Lebedenko; Sergey M Deyev
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.